Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 18/12/20131 min di lettura
Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) (the Agencies) are announcing the extension of the "Pilot Program for Parallel Review of Medical Products." The Agencies have decided to continue the program as currently designed for an additional period of 2 years from the date of publication of this notice.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →